<DOC>
	<DOCNO>NCT00215423</DOCNO>
	<brief_summary>The purpose study determine dose investigational drug safe effective treatment COPD compare control drug</brief_summary>
	<brief_title>Study Patients With COPD</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Formoterol Fumarate</mesh_term>
	<criteria>Diagnosis COPD History cigarette smoke Clinical diagnosis asthma Significant pulmonary disease COPD Other significant major organ disease ( )</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2008</verification_date>
	<keyword>COPD</keyword>
	<keyword>Chronic Obstructive Pulmonary Disease</keyword>
	<keyword>Formoterol Fumarate</keyword>
	<keyword>Formoterol</keyword>
</DOC>